Abstract
BackgroundThe inhaled corticosteroid fluticasone furoate (FF) in combination with the long-acting β2 agonist vilanterol (VI) is in development for asthma and chronic obstructive pulmonary disease.ObjectiveTo assess the safety and tolerability...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have